Neurothrombectomy Devices Market Share

North American Market Forecast

North America industry is predicted to hold largest revenue share of 36% by 2037. The growth of the market can be attributed majorly to the increasing occurrence of ischemic strokes in the region. For instance, each year, around 798,000 people in the United States suffer from a stroke. Out of these strokes, approximately 615,000 are first or new strokes. Moreover, ischemic strokes account for around 88% of all these strokes. Further, the high spending on healthcare, along with adequate reimbursement policies for the treatment of ischemic strokes, is also anticipated to contribute to the market growth in the region. In addition, an upsurge in the geriatric population, followed by escalating investment in the healthcare sector, and proliferating adoption of neurology devices are also anticipated to boost the market growth in the region during the forecast period.

Europe Market Forecast

Furthermore, the Europe neurothrombectomy devices market is also projected to display notable market growth by the end of 2037. The growth of the market can be attributed to the growing patient ratio who are suffering from acute ischemic stroke. In addition to this, the surging count of mechanical thrombectomy processes done in this region is another significant factor that is estimated to accelerate the growth of the market during the forecast period. Moreover, growing public and private investment in healthcare is another key factor that is expected to boost market growth further throughout the projected time frame in the European region.